RETRACTED: Lin et al. miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas. Cancers 2018, 10, 272

Shih-Shen Lin, Chih-Yu Peng, Yi-Wen Liao, Ming-Yung Chou, Pei-Ling Hsieh, Cheng-Chia Yu · 2026

Read RETRACTED: Lin et al. miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas. Cancers 2018, 10, 272 by Shih-Shen Lin, Chih-Yu Peng, Yi-Wen Liao, Ming-Yung Chou, Pei-Ling Hsieh, Cheng-Chia Yu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13395185.txt.

Description

The journal Cancers retracts, in a 2026 notice, a 2018 study by Shih-Shen Lin and co-authors on a small RNA in mouth cancer. The study claimed the RNA, miR-1246, boosts cancer stem traits and drug resistance by targeting a gene named CCNG2. After publication, doubts arose about the honesty of its figures. An inquiry found panels that overlap with figures in an earlier paper from a like group, said to show other tests.

The authors helped with the inquiry and offered a correction. The board judged that their account and materials could not clear the doubts. The editor-in-chief approved the retraction under publisher policy. The authors were told and said they disagree with the step.

Catalog record

CREATORShih-Shen Lin, Chih-Yu Peng, Yi-Wen Liao, Ming-Yung Chou, Pei-Ling Hsieh, Cheng-Chia Yu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE1425
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13395185

Browse the full library · About the Tower of Babel